Simplex Trading’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.1K Sell
6,905
-21,158
-75% -$182K ﹤0.01% 5746
2025
Q4
$292K Sell
28,063
-118,108
-81% -$1.24M ﹤0.01% 3846
2025
Q3
$1.29M Buy
146,171
+141,962
+3,373% +$1.01M ﹤0.01% 2783
2025
Q2
$24K Sell
4,209
-10,654
-72% -$65.3K ﹤0.01% 6607
2025
Q1
$98K Buy
+14,863
New +$116K ﹤0.01% 5078
2024
Q2
Sell
-23,746
Closed -$488K 9340
2024
Q1
$506K Buy
23,746
+16,201
+215% +$315K ﹤0.01% 3851
2023
Q4
$108K Buy
7,545
+7,330
+3,409% +$72.1K ﹤0.01% 5302
2023
Q3
$1K Sell
215
-4,228
-95% -$42.9K ﹤0.01% 8335
2023
Q2
$47K Buy
+4,443
New +$52.5K ﹤0.01% 5913
2021
Q4
Sell
-5,070
Closed -$82.1K 10952
2021
Q3
$110K Sell
5,070
-1,597
-24% -$30.1K ﹤0.01% 6482
2021
Q2
$139K Buy
6,667
+3,969
+147% +$98.5K ﹤0.01% 6252
2021
Q1
$76K Sell
2,698
-15,048
-85% -$476K ﹤0.01% 6112
2020
Q4
$579K Buy
+17,746
New +$624K ﹤0.01% 3229
2020
Q3
Sell
-17,287
Closed -$382K 8135
2020
Q2
$281K Buy
17,287
+13,944
+417% +$201K ﹤0.01% 3604
2020
Q1
$33K Buy
3,343
+2,416
+261% +$27.7K ﹤0.01% 5548
2019
Q4
$12K Buy
+927
New +$13.7K ﹤0.01% 6286
2019
Q2
Sell
-267
Closed -$4.43K 7458
2019
Q1
$4K Sell
267
-10,331
-97% -$159K ﹤0.01% 6568
2018
Q4
$148K Buy
10,598
+6,008
+131% +$79.6K ﹤0.01% 3473
2018
Q3
$80K Buy
4,590
+3,260
+245% +$62.5K ﹤0.01% 4673
2018
Q2
$24K Buy
+1,330
New +$22.5K ﹤0.01% 5721

Other funds holding KURA

Simplex Trading's KURA Position: Q1 2026 in Review

Simplex Trading reduced its Kura Oncology (KURA) stake by 75% in Q1 2026, selling an estimated $182K and leaving 6,905 shares worth $56.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5746.

Simplex Trading first reported a position in KURA in Q2 2018 and has held it in 20 quarters since. The position peaked at $1.29M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Simplex Trading held 6,905 shares of Kura Oncology worth $56.1K as of Q1 2026.
  • Simplex Trading sold 21,158 Kura Oncology shares in Q1 2026, an estimated $182K.
  • Kura Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #5746 holding.
  • Simplex Trading first reported a position in Kura Oncology in Q2 2018 and has held it in 20 quarters since.
  • Simplex Trading's Kura Oncology position peaked at $1.29M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.